Company Announcements - 2013
-
Appendix 4C31 January 2014
Analytica Limited presents its Appendix 4C for the quarter ended 31st December 2013
-
Analytica selected as a Bioshares Top Six Stock Picks for 201420 December 2013
Analytica Ltd has been selected as a Bioshares Top Six Stock Picks for 2014, and been added to the Bioshares portfolio as a "Speculative Buy Class B" rating.
-
Analytica in The Australian Top Stocks for 201428 December 2013
Analytica Ltd has been chosen as a "Rising Star" in The Australian newspaper's Top 100 stock picks for 2014.
-
December Shareholder Newsletter19 December 2013
Analytica presents the final shareholder newsletter for 2013.
-
Investor Presentations26 November 2013
Analytica Ltd presents the attached investor brief to be presented to a number of stockbroking organisations in Melbourne, Brisbane, Sydney and other locations over the next few weeks.
-
Notice under Section 708A of the Corporations Act15 November 2013
-
Form 60413 November 2013
Notice of change of interests of substantial holder.
-
Form 60513 November 2013
Notice of ceasing to be a substantial holder.
-
Appendix 3Y13 November 2013
Change of Director’s Interest Notice (x3).
-
PeriCoach System registered on the Australian Register of Therapeutic Goods (ARTG)13 November 2013
Analytica (ASX:ALT) takes great pleasure in announcing that it has successfully registered the PeriCoach® System with the Australian Therapeutic Goods Administration.
-
Appendix 3B11 November 2013
Analytica has today allotted securities as a result of the recent AGM and Share Purchase Plan.
-
SPP Result8 November 2013
Analytica is pleased to announce it has successfully raised $2.2m in the recent SPP.
-
Appendix 4C - Quarterly Cash Flow31 October 2013
Analytica presents its Appendix 4C for the quarter ending September 30, 2013.
-
Results of AGM30 October 2013
Analytica advises that all resolutions were passed.
-
AGM 2013 Presentations30 October 2013
Analytica presents the Chairman's address and Operations Report to be delivered at tonight's AGM in Brisbane.
-
Investor Presentation24 October 2013
Analytica presents the attached updated presentation made to stockbrokers in Perth today.
-
Analytica Receives $514k from R&D Tax Incentive24 October 2013
Analytica Limited (ASX:ALT), has received $514k from the Australian Taxation Office under the Research and Development Tax Incentive relating to the financial year to 30 June 2013. These funds will be applied to the Analytica’s product development programme and in particular to further advance the rollout of the PeriCoach® system.
-
First PeriCoach Production22 October 2013
Analytica is proud to announce that the first production PeriCoach units came off the assembly line at our Sydney manufacturer yesterday. These units are the first in a limited production run to provide units for validation testing, marketing purposes, and field testing by volunteer women. This limited production build is expected to last several weeks and will also be used to develop manufacturing processes and techniques for future high volume manufacturing runs.
-
Formation of PeriCoach Clinical Advisory Board9 October 2013
Analytica is proud to announce the formation of a Clinical Advisory Board for the PeriCoach® system.
-
Notice of Annual General Meeting / Proxy Form30 September 2013
Analytica's Annual General Meeting will be held at 6:00pm Wednesday, 30 October 2013 at The Greek Club, 29 Edmondstone Street, South Brisbane QLD 4101.
-
Share Purchase Plan30 September 2013
Chairman's Letter to shareholders and SPP documentation including application form.
-
PeriCoach Update Newsletter30 September 2013
PeriCoach Progress Update.
-
Share Purchase Plan27 September 2013
Analytica is pleased to announce a Share Purchase Plan underwritten to $1.8 million, providing shareholders with an opportunity to increase their holding in the company as it continues to advance a number of exciting opportunities.
-
Cleansing Statement27 September 2013
Analytica is proposing to issue to eligible shareholders the opportunity to subscribe to additional shares in the Company under the Share Purchase Plan. In accordance with ASIC Class Order 09/425 Analytica has issued a 'Cleansing Statement'
-
Investor Presentation27 September 2013
Analytica discloses the presentation made to the SPP underwriters on 25 Sept 2013
-
Annual Report for the year Ended 30 June 201330 August 2013
-
Appendix 4E and Financial Statements for the year Ended 30 June 201330 August 2013
-
WiseOwl.com Research Report28 August 2013
Analytica Limited (ASX:ALT) is pleased to advise the release of an independent research report from Wise-Owl.com.
-
Chinese Patent granted for the AutoStart Infusion System14 August 2013
Analytica is pleased to announce a further opportunity for overseas sales by securing a patent covering the company's core AutoStart system intellectual property in the enormous market of the People’s Republic of China.
-
Investor Information Presentation Slides12 August 2013
Slides used in the Investor Information Presentations Aug 12-14.
-
Appendix 4C31 July 2013
Quarterly Cash Flow.
-
Investor Presentations in Brisbane, Sydney and Sunshine Coast30 July 2013
Analytica is pleased to announce a series of investor presentations to be held in Brisbane, Sydney and the Sunshine Coast in mid-August. Download the announcement for further details.
-
Chairman's Letter to Shareholders and PeriCoach Newsletter25 July 2013
A letter from the Chairman updating shareholders on AutoStart product sales, our efforts to improve shareholder communication and introducing the PeriCoach system.
-
Chinese Patent Granted for AutoFlush Feature.24 July 2013
Analytica is pleased to announce that a Chinese patent titled "Flushable Injection Port" patent number ZL20098012636.9 has been granted to Analytica.
-
Form 60424 July 2013
Notice of change of interests of substantial holder.
-
AutoStart System Mandarin Videos Released8 July 2013
Analytica has released Mandarin translations of the AutoStart Infusion System promotional and training videos to assist our Taiwanese Distributors.
-
Appendix 3Y (x2)3 July 2013
Change of Director’s Interest Notices.
-
Appendix 3Y (x3)14 June 2013
Change of Director’s Interest Notices.
-
Taiwan Distribution Agreement Signed7 June 2013
Analytica is pleased to announce the signing of a distribution agreement for the AutoStart® Infusion System with a major medical products distributor in Taiwan – Taiwan Allied Dragon Inc.
-
Trading Halt5 June 2013
Analytica Limited hereby requests a trading halt on its securities, effective immediately.
-
Receipt of Research and Development cash rebate of $487k30 May 2013
Analytica is pleased to inform the market it has received a $487k cash rebate from the Commonwealth Government. The expected receipt of these funds was set out in the quarterly 4C - quarterly cash report – released to the market in April.
-
Letter of Intent signed with Taiwanese Distributor20 May 2013
Analytica is pleased to announce that it has secured a letter of intent from a major medical products distributor in Taiwan - Taiwan Allied Dragon Inc.
-
Letter to Option Holders10 May 2013
-
Appendix 4C - Quarterly Cash Flow30 April 2013
Analytica Limited presents its Appendix 4C for the quarter ended 31 March 2013
-
Appendix 4D and Half-Year Financial Report28 February 2013
-
South-East Asia Marketing Initiative21 February 2013
Analytica is pleased to announce the signing of a corporate advisory agreement with South-South Capital Partners to take our AutoStart Burette technology into Indonesia, Malaysia, The Philippines, Singapore, Taiwan and Thailand.
-
Appendix 4C30 January 2013
Analytica presents its Quarterly Cash Flow for the quarter ended December 2012.